InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.96
(
1.02%
)
US TECH 100
17,243.20
(
1.56%
)
Dow Jones
38,239.66
(
0.40%
)
Brent Oil
88.17
(
0.02%
)
Bitcoin
63,821.51
(
-1.03%
)
Post# of 251620
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BiotechValues

Send PM Follow Ignore
Followers 355
Posts 9910
Boards Moderated 2
Alias Born 06/23/2007

BiotechValues

Re: None

Monday, 02/27/2017 10:16:20 AM

Monday, February 27, 2017 10:16:20 AM

Post# of 251620
$TPIV - Immuno-Oncology Vaccines in Four Phase II trials

Partners with $AZN, Mayo Clinic, and received a $13.3 million grant fully funding Phase II trial of vaccine TPIV 200 in 280 patients with triple negative breast cancer being conducted at Mayo Clinic

Market cap $36M seems too low given cash balance and government funding imo.

Investor deck:

http://microcapresearch.com/wp-content/uploads/2017/03/TapImmune-Investor-Deck-1.05.16-FINAL-v4.pdf




IRP Disclosure

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up